NEW – Healthcare Trust of America, Inc. Announces Pricing of Public Offering of Common Stock

SCOTTSDALE, ARIZONA, November 4, 2014 Healthcare Trust of America, Inc. (NYSE: HTA) announced today the pricing of its underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $12.55 per share. HTA has granted the underwriters a 30-day option to purchase up to 1,200,000 additional shares of its common stock.

HTA will receive approximately $100.4 million in gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses.  HTA intends to use net proceeds from the offering to repay a portion of the outstanding indebtedness under the senior unsecured revolving credit and term loan facility and for general corporate purposes, including, without limitation, working capital and investment in real estate.  Closing is expected to occur on or about November 7, 2014, subject to customary closing conditions.

J.P. Morgan and Wells Fargo Securities are acting as the joint book-running managers for the offering.  BMO Capital Markets, PNC Capital Markets LLC and Raymond James are acting as the lead managers for the offering.  Baird, Capital One Securities, Sandler O’Neill + Partners, L.P., Scotiabank and Stifel are acting as the co-managers for the offering.

To obtain a copy of the prospectus supplement and related base prospectus for this offering, please contact: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 375 Park Avenue, New York, New York, 10152, at (800) 326-5897 or email a request to cmclientsupport@wellsfargo.com.

A registration statement relating to these securities has been filed with and declared effective by the Securities and Exchange Commission. This announcement shall not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful under the securities laws of any such jurisdiction.  The offering of these securities is being made solely by means of a prospectus supplement and the accompanying prospectus.

About Healthcare Trust of America, Inc.
Healthcare Trust of America, Inc. (NYSE:HTA), a publicly traded real estate investment trust, is a full-service real estate company focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on or aligned with campuses of nationally or regionally recognized healthcare systems in the U.S.  Since its formation in 2006, HTA has invested approximately $3.3 billion to build a portfolio of properties that is comprised of approximately 14.6 million square feet of gross leasable area located in 27 states. It operates its properties through regional offices in Scottsdale, Albany, Atlanta, Boston, Charleston, Dallas, Indianapolis, Miami and Pittsburgh.

FORWARD-LOOKING LANGUAGE
This press release contains certain forward-looking statements. Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.

The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA’s control. Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA’s actual results and performance could differ materially and in adverse ways from those set forth in the forward-looking statements. Factors which could have a material adverse effect on HTA’s operations and future prospects include, but are not limited to:

•  changes in economic conditions affecting the healthcare property sector, the commercial real estate market and the credit market;

•  competition for acquisition of medical office buildings and other facilities that serve the healthcare industry;

•  economic fluctuations in certain states in which HTA’s property investments are geographically concentrated;

•  retention of HTA’s senior management team;

•  financial stability and solvency of HTA’s tenants;

•  supply and demand for operating properties in the market areas in which HTA operates;

•  HTA’s ability to acquire real properties, and to successfully operate those properties once  acquired;

•  changes in property taxes;

•  legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry;

•  fluctuations in reimbursements from third party payors such as Medicare and Medicaid;

•  delays in liquidating defaulted mortgage loan investments;

•  changes in interest rates;

•  the availability of capital and financing;

•  restrictive covenants in HTA’s credit facilities;

•  changes in HTA’s credit ratings;

•  HTA’s ability to remain qualified as a REIT;

•  changes in accounting principles generally accepted in the United States of America, policies and guidelines applicable to REITs; and

•  the risk factors set forth in HTA’s 2013 Annual Report on Form 10-K for the year ended December 31, 2013 and in HTA’s Quarterly Reports on Form 10-Q.

Forward-looking statements speak only as of the date made. Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.